OncoDaily’s Post

5-Minute High-Intensity Interval Training for cancer survivors - Sami (Papacek) Mansfield https://lnkd.in/df2X_25E #OncoDaily #Oncology #Cancer #Health #Medicine #CancerSurvivors

The current treatment landscape/algorithm for Ovarian Cancer with Martina Murphy - Rahul Gosain, MD, MBA Rohit Gosain, MD https://lnkd.in/eG9g3__U #OvarianCancer #OncoDaily #Oncology #Cancer #Health #Medicine

Here's why events like the Global R&D Summit at #Labcorp are truly impactful. They unite top minds within the organization to celebrate scientific achievements and foster collaboration across various business units. A stimulating conversation with Sarabjot Pabla inspired this insightful article. Sabi discusses the inherent contradiction within precision oncology: the balance between highly personalized treatments and the challenges of scaling these solutions to benefit a larger population. Precision oncology offers transformative potential by customizing treatment based on individual genetic profiles, but the same granularity limits broad application due to economic, logistical, and technological hurdles. This shift complicates clinical trials and regulatory processes due to the need for specific patient cohorts. Ultimately the future success of precision oncology will depend on reconciling the tension between personalization and practicality in scaling healthcare delivery, recognizing that addressing these challenges is crucial for realizing the benefits of precision medicine on a global scale. #precisiononcology

We must not give up on MDM2 inhibitors in LPS - Sebastian Bauer https://lnkd.in/dd86mRqd Herbert Loong, MBBS FRCP FASCO #Cancer #CancerResearch #CancerTreatment #Medicine #CancerDrug #Health #Oncology #OncoDaily

My latest article exploring the fascinating world of precision oncology and its inherent challenges - Sarabjot Pabla Janice Cutinho https://lnkd.in/eW43ZcfM #CancerTreatment #Cancer #OncoDaily #Oncology #PrecisionOncology #Medicine #Health

Polygenic Risk Score in Breast Cancer Risk Assessment – Stephanie Graff, MD, FACP, FASCO (Brown University) https://lnkd.in/gziChyAq #Health #Medicine #Cancer #OncoDaily #Oncology #BreastCancer #RiskAssessment

EORTC - European Organisation for Research and Treatment of Cancer - Challenges and opportunities of conducting investigator-initiated clinical trials in Portugal Ana Joaquim https://lnkd.in/e-hu9-W3 #CancerResearch #ClinicalTrials #OncoDaily #Oncology #Cancer #Health #Medicine

Novel scenarios for unresectable stage III NSCLC discussed by Antonio Nuccio and Matteo Sepulcri Roberto Ferrara https://lnkd.in/emJCtkpF #OncoDaily #Oncology #Cancer #Health #Medicine #NSCLC

Not one size fits all – protecting all people in cancer care - Shona Edwards https://lnkd.in/dBypqVaR Clinical Oncology Society of Australia (COSA) #Cancer #CancerCare #CancerPatient #PatientCare #COSA24 #Medicine #Health #CancerConsumer #Oncology #OncoDaily

Exploring the Future of AI in Precision Oncology - Nikhil Thaker, MD Douglas Flora, MD, LSSBB, FACCC https://lnkd.in/eMFEuTft #ClinicalTrials #AIinOncology #OncoDaily #Oncology #Cancer #Health #Medicine